JAUNDICE AND ASCITES An Approach to the Patient with Suspected Liver Disease.
-
Upload
john-bridges -
Category
Documents
-
view
225 -
download
0
Transcript of JAUNDICE AND ASCITES An Approach to the Patient with Suspected Liver Disease.
JAUNDICE AND ASCITES
An Approach to the Patient with Suspected Liver Disease
Objectives:
1. discuss the pathophysiology of jaundice and ascites
2. do a complete history and physical examination on a patient with liver disease
3. know the significance of liver-laboratory tests
4. evaluate a patient with liver disease
Hyperbilirubinemia
1. overproduction of bilirubin 2. impaired uptake, conjugation, or
excretion of bilirubin 3. regurgitation of unconjugated or
conjugated bilirubin from damaged hepatocytes or bile ducts
Unconjugated hyperbilirubinemia Conjugated hyperbilirubinemia
Evaluating a patient with jaundice
1. determine whether conjugated or unconjugated hyperbilirubinemia
2. determine presence of other abnormal laboratory tests
In a patient with jaundice, a careful history, physical examination, and review of standard laboratory tests should permit a physician to make an accurate diagnosis in 85% of cases.
Franz Ingelfinger, MD
1958
Causes of Jaundice
1. viral hepatitis 2. alcohol-induced liver disease 3. chronic active liver disease 4. drug-induced liver disease 5. gallstones and their complications 6. carcinoma of the pancreas 7. primary biliary cirrhosis 8. sclerosing cholangitis
Clinical History Related to viral hepatitis
Blood transfusions IV drug use Sexual practices Contact with jaundiced persons Needle stick exposure Work in renal dialysis unit Body piercing/tattoos Travel to endemic areas
Clinical History
Medication related Review all prescription medications Over-the-counter drugs Use of vitamins, especially vit A Herbal preparations Food supplements Home remedies purchased in health food
store
Clinical History
Alcohol use Detailed quantitative history of both
recent and previous alcohol from patient and family members
History of withdrawal symptoms CAGE criteria Evidence of alcohol associated illnesses
(pancreatitis, perpheral neuropathy)
Quantification of alcohol intake 1 oz whiskey contains 10-11 g alcohol 1 12-oz beer contains 10-11 g alcohol 4 oz red wine contains 10-11g alcohol
Ingestion of >3 units/day everyday or 21 units/week every week is excessive.
Threshold for alcohol-induced hepatic injury appears to be 30 gm for women and 60 gm for men if ingested >10 yrs
CAGE criteria
1. has the patient tried to cut back on alcohol use?
2. does the patient become angry when asked about his alcohol intake?
3.does the patient feel guilty about his alcohol use?
4. does the patient need an eye opener in the morning?
Clinical History
Miscellaneous Pruritus Evolution of jaundice Recent changes in menstrual cycle History of anemia Symptoms of biliary tract disease Family history of liver disease,
gallbladder disease Occupational history
Physical Examination General inspection
Scleral icterus Pallor Wasting Needle tracks Skin excoriations Ecchymosis/petechiae Muscle tenderness and weakness Lymphadenopathy Evidence of congestive heart failure
Physical Examination
Peripheral stigmata of liver disease Spider angiomata Palmar erythema Gynecomastia Dupuytren’s contracture Parotid enlargement Testicular atrophy Paucity of axillary and pubic hair
Physical Examination
Abdominal examination Hepatomegaly Splenomegaly Ascites Prominent abdominal collateral veins Bruits and rubs Abdominal masses Palpable gallbadder
Liver Liver span is about 10-12 cm in men, and 8-
11 cm in women Normal liver is non-tender, sharp-edged,
smooth and not hard, left lobe not palpable Modest hepatomegaly in viral hepatitis,
chronic hepatitis, cirrhosis Marked enlargement in tumors, fatty liver,
severe congestive heart failure Pulsatile liver in tricuspid regurgitation
Spleen
Normally not palpable Enlarged in portal hypertension
because of cirrhosis Splenomegaly also seen in infections,
leukemias, lymphomas, infiltrative disorders, hemolytic disorders, etc
Gallbladder Not normally palpable Palpable in 25% of cancer of the head of
the pancreas (Courvoisier’s law) Palpable in about 30% of cholecystitis,
usually because of stone impacted in neck of gallbladder
Palpable in the RUQ at the angle formed by the lateral border of the rectus abdominis muscle and the right costal margin
Ascites
Assessed on physical examination by: Shifting dullness Fluid wave Puddle sign Bulging flanks
Both shifting dullness and fluid wave test will not uniformly detect fluid less than 1000 ml
Both tests have a sensitivity of about 60% when compared with ultrasound
Confirmation of presence of ascites by imaging procedures
Tests can be spuriously positive in obese patients
Causes of ascites:
1. cirrhosis 2. congestive heart failure 3. nephrosis 4. disseminated carcinomatosis
Laboratory findings
Because many of the clinical features of liver injury are non-specific, the history and physical examination are routinely supplemented by “liver function” tests, which are so widely available that they have become a standard and esssential component of the evaluation.
Biochemical Liver Tests
Hepatocellular NecrosisAminotransferasesLactic Dehydrogenase
CholestasisAlkaline PhosphataseGamma Glutamyl TranspeptidaseBilirubin
Hepatic Synthetic ActivityProthrombin timeAlbumin
Aminotransferases Increased levels results from leakage
from damaged tissues, released from damaged hepatocytes following injury or death
AST not exclusive for liver, also found in heart, muscle, kidney, brain, pancreas and erythrocytes.
Confirm liver injury by doing ALT which is almost exclusive to liver
Aminotransferases
Acute elevations to >1000 IU reflect severe hepatic necrosis and usually seen in viral hepatitis, toxin-induced hepatitis and hepatic ischemia.
AST/ALT >2 with AST level of <300IU is suggestive of alcohol-induced liver disease. Higher AST levels in viral hepatitis, ischemia and other liver injuries.
AminotransferasesAST and ALT levels Poorly correlates with the extent of
hepatocyte injury Not predictive of outcome Azotemia can lower AST level Persistent elevation of AST from
macroenzyme complex with albumin
Etiology of mild ALT/AST elevations
ALT predominant Chronic hepatitis B & C Acute hepatitis A & E Steatosis / steatohepatitis Medications / toxins autoimmune hepatitis
AST predominant Alcohol-related liver disease Steatosis / steatohepatitis cirrhosis
Etiology of mild ALT/AST elevations
Nonhepatic Hemolysis Myopathy Thyroid disease Strenuous exercise
Time Course of ALT
1 2 3 40 Weeks
5000
1000
ALT(U/L)
Ischemia/ToxinViral/Drug
Lactic Dehydrogenase (LDH)
Wide tissue distribution Massive but transient elevation in
ischemic hepatitis Sustained elevation with elevated
alkaline phosphatase in malignant infiltration of the liver
Alkaline Phosphatase
Major sources: bone and liver Others: intestine, placenta, adrenal
cortex, kidney and lung Increased levels because of increased
synthesis and release from damaged cells
Marked increase in infiltrative hepatic disorders or biliary obstruction
Alkaline Phosphatase
Marked increases seen in ductular injury – intrahepatic cholestasis, infiltrative process, extrahepatic biliary obstruction, biliary cirrhosis, malignancy and organ rejection
Lesser increase in viral hepatitis, cirrhosis and congestive hepatopathy
Gamma Glutamyl Transpeptidase (GGTP)
Wide distribution Not found in bone Main use: determine if elevation in AP is
liver rather than bone in origin Induced by alcohol and drugs GGTP/AP ratio > 2 suggests alcohol abuse Isolated elevations are non-specific, most
cases not associated with clinically significant liver disease
5 ‘ Nucleotidase
Wide distribution Significant elevations in liver disease Sensitivity comparable to AP
detecting obstruction, infiltration, cholestasis
Measurement of serum bilirubin(van den Bergh reaction)
Direct fraction = conjugated bilirubin = B1- fraction that reacts with diazotized sulfanilic acid in the absence of an accelerator
Total bilirubin - amount that reacts with diazotized sulfanilic acid in the presence of an accelerator
Indirect fraction = unconjugated bilirubin = B2- the difference between total and direct fraction
Normal serum bilirubin
Total bilirubin3.4-15.4 uml0.2-1 mg/dL
Direct bilirubin5.1 uml0.3 mg/dL
Bilirubin
Serum bilirubin level normally almost unconjugated
Bilirubin in urine is conjugated thus indicative of hepatobiliary disease
In chronic hemolysis with normal liver, levels usually not more than 5 mg/dl
Magnitude of elevation useful prognostically in alcoholic hepatitis and acute liver failure
Urine bilirubin
Bilirubin found in the urine is conjugated bilirubin
Unconjugated bilirubin is bound to albumin in the serum; it is not filtered by the kidney; and is not found in the urine
Prothrombin Time
Most important predictor of outcome in acute liver failure
Useful in monitoring hepatic synthetic function
Useful indicator of liver failure in both acute and chronic hepatic injury provided that cholestasis with malabsorption of Vit K has been excluded
Albumin
Half life of 20 days Less useful than prothrombin time in
monitoring acute liver disease because of long half life
Correlates with prognosis in chronic liver disease- used for grading system
HEPATOCELLULAR NECROSIS
Toxin/Ischemia Viral Hepatitis
Alcohol
Aminotransferases 50-100x 5-50x 2-5x
AP 1-3x 1-3x 1-10x
Bilirubin 1-5x 1-30x 1-30x
Prothrombin time
Prolonged & unresponsive to Vitamin K in severe disease
Albumin Decreased in subacute/chronic disease
Characteristic Biochemical Patterns:
BILIARY OBSTRUCTIONComplete Partial
Pancreatic CA Hilar tumor, PSC
Aminotransferases 1-5x 1-5xAP 2-20x 2-20xBilirubin 1-30x 1-5xProthrombin time
Often prolonged & responsive to parenteral vitamin K
Albumin Usually normal, decreased in advanced disease
Characteristic Biochemical Patterns:
Characteristic Biochemical Patterns:
HEPATIC INFILTRATION
Aminotransferases 1-3x
AP 1-20x
Bilirubin 1-5x (often normal)
Prothrombin time Usually normal
Albumin Usually normal
History & PELaboratory tests
Isolated elevationOf bilirubin
Bilirubin & otherLiver tests elevated
Isolated elevation of bilirubin
Indirect hyperbilirubinemia(Direct < 15%)
Direct hyperbilirubinemia(Direct > 15%)
Drugs: Rifampicin Probenecid
Inherited disorders:Gilbert’s syndrome
Hemolytic disordersIneffective erythropoieisis
Inherited disorders:Dubin-Johnson syndrome
Rotor’s syndrome
Bilirubin & other liver testselevated
Hepatocellular pattern: ALT/AST elevated out of proportion to alkaline phosphatase
Cholestatic pattern: Alkaline phosphatase out of proportion ALT/AST
Hepatocellular pattern
1. Viral serologies Hepatitis A IgM Hepatitis B surface antigen & core antibody Hepatitis C RNA2. Toxicology screen Acetaminophen level3. Ceruloplasmin (if patient less than 40 yrs of age)4. ANA, SMA, LKM, SPEP
Additional virologic testing: CMV DNA, EBV capsid antigen Hepa D antibody (if indicated) Hepa E IgM (if indicated)
Liver biopsy
Results (-)
Results (-)
Results (-) AMA (+)
Cholestatic pattern
Ultrasound
Dilated ductsExtrahepatic cholestasis
Ducts not dilatedIntrahepatic cholestasis
CT/ERCPSerologic testing: AMA Hepatitis serologies Hepatitis A, CMV, EBVReview drugs
ERCP/ Liver biopsy Liver biopsy